Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,430 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma.
Ma S, Li H, Zhou D, Zhang X, Shi M, Cao J, Qi Y, Xia J, Liu Y, Wang X, Li D, Sang W, Yan Z, Zhu F, Sun H, Cheng H, Zheng J, Xu K, Li Z, Qi K, Wang Y. Ma S, et al. Among authors: shi m. Cytotherapy. 2023 Jun;25(6):653-658. doi: 10.1016/j.jcyt.2023.01.011. Epub 2023 Mar 11. Cytotherapy. 2023. PMID: 36907717
A combination of pre-infusion serum ferritin, CRP and IL-6 predicts outcome in relapsed/refractory multiple myeloma patients treated with CAR-T cells.
Liu Y, Jie X, Nian L, Wang Y, Wang C, Ma J, Jiang J, Wu Q, Qiao J, Chen W, Cao J, Yan Z, Shi M, Cheng H, Zhu F, Sang W, Li D, Chen C, Xu K, Li Z. Liu Y, et al. Among authors: shi m. Front Immunol. 2023 Apr 19;14:1169071. doi: 10.3389/fimmu.2023.1169071. eCollection 2023. Front Immunol. 2023. PMID: 37153543 Free PMC article.
Bispecific BCMA/CD19 targeted CAR-T cell therapy forces sustained disappearance of symptoms and anti-acetylcholine receptor antibodies in refractory myasthenia gravis: a case report.
Zhang Y, Liu D, Zhang Z, Huang X, Cao J, Wang G, Du X, Wang Z, Yang M, Luo T, Liu S, Zhang W, Sheng Y, Li H, Zhang W, Chen H, Zhang S, Wang X, Meng W, Zong S, Shi M, Zheng J, Cui G. Zhang Y, et al. Among authors: shi m. J Neurol. 2024 Apr 11. doi: 10.1007/s00415-024-12367-4. Online ahead of print. J Neurol. 2024. PMID: 38602546 No abstract available.
Complex association of body mass index and outcomes in patients with relapsed and refractory multiple myeloma treated with CAR-T cell immunotherapy.
Cheng H, Sun Y, Zhang X, Chen Z, Shao L, Liu J, Wang D, Chen Y, Wang X, Chen W, Sang W, Qi K, Li Z, Sun C, Shi M, Qiao J, Wu Q, Zeng L, Zheng J, Xu K, Cao J. Cheng H, et al. Among authors: shi m. Cytotherapy. 2024 Mar 29:S1465-3249(24)00572-3. doi: 10.1016/j.jcyt.2024.03.481. Online ahead of print. Cytotherapy. 2024. PMID: 38625072
CRISPR screens in mechanism and target discovery for AML.
Lin T, Liu D, Guan Z, Zhao X, Li S, Wang X, Hou R, Zheng J, Cao J, Shi M. Lin T, et al. Among authors: shi m. Heliyon. 2024 Apr 9;10(8):e29382. doi: 10.1016/j.heliyon.2024.e29382. eCollection 2024 Apr 30. Heliyon. 2024. PMID: 38660246 Free PMC article. Review.
7,430 results